OraSure Technologies, Inc. (NASDAQ:OSUR - Get Free Report)'s stock price passed below its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of $3.57 and traded as low as $3.40. OraSure Technologies shares last traded at $3.46, with a volume of 502,792 shares traded.
Wall Street Analyst Weigh In
OSUR has been the subject of a number of research analyst reports. Craig Hallum raised shares of OraSure Technologies to a "strong-buy" rating in a research report on Friday, October 23rd. Zacks Research raised OraSure Technologies to a "hold" rating in a research report on Friday, October 2nd. Weiss Ratings restated a "sell (d-)" rating on shares of OraSure Technologies in a research note on Tuesday, September 1st. Finally, Wall Street Zen raised OraSure Technologies from a "sell" rating to a "hold" rating in a report on Monday, August 10th. One analyst has rated the stock with a Strong Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, OraSure Technologies presently has an average rating of "Hold".
Check Out Our Latest Report on OraSure Technologies
OraSure Technologies Stock Down 4.2%
The stock has a market capitalization of $238.91 million, a price-to-earnings ratio of -5.01 and a beta of 1.08. The stock's 50-day simple moving average is $3.74 and its 200 day simple moving average is $3.57.
OraSure Technologies (NASDAQ:OSUR - Get Free Report) last issued its quarterly earnings data on Monday, November 9th. The medical instruments supplier reported ($0.15) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.20) by $0.05. The firm had revenue of $30.91 million during the quarter, compared to the consensus estimate of $31.00 million. OraSure Technologies had a negative return on equity of 19.81% and a negative net margin of 41.73%. As a group, equities research analysts anticipate that OraSure Technologies, Inc. will post -0.96 earnings per share for the current year.
Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of OSUR. Altai Capital Management L.P. bought a new stake in shares of OraSure Technologies during the second quarter worth $16,118,000. BlackRock Inc. acquired a new stake in OraSure Technologies in the second quarter worth about $27,905,000. Cannell Capital LLC acquired a new stake in OraSure Technologies in the second quarter worth about $6,366,289. Bank of New York Mellon Corp bought a new stake in OraSure Technologies during the 2nd quarter worth about $926,000. Finally, Marquette Asset Management LLC bought a new stake in OraSure Technologies during the 2nd quarter worth about $601,000. Institutional investors own 93.50% of the company's stock.
About OraSure Technologies
(
Get Free Report)
OraSure Technologies develops, manufactures and markets diagnostic tests and specimen-collection products for healthcare and public health. Its offerings include rapid tests for infectious diseases, including HIV and hepatitis C, as well as oral-fluid collection devices designed for use in clinical and other settings. Through its DNA Genotek business, OraSure also provides collection kits and related services for genetic and microbiome testing. Products include the Oragene and OMNIgene lines, which allow biological samples to be collected and transported for laboratory analysis.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider OraSure Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and OraSure Technologies wasn't on the list.
While OraSure Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.